Terms: = Brain cancer AND TRIM24, O15164, 8805, ENSG00000122779, TIF1ALPHA, TF1A, TIF1A, hTIF1, Tif1a, TIF1, RNF82, PTC6
16 results:
1. Valproic Acid Inhibits Glioma and Its Mechanisms.
Yang ZY; Wang XH
J Healthc Eng; 2022; 2022():4985781. PubMed ID: 35251569
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma.
Han M; Sun Y
J Transl Med; 2021 Dec; 19(1):505. PubMed ID: 34886858
[TBL] [Abstract] [Full Text] [Related]
3. The Effects of Melatonin Administration on Intestinal Injury Caused by Abdominal Irradiation from Mice.
Wang Q; Wang Y; Du L; Xu C; Liu Q; Fan S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575874
[TBL] [Abstract] [Full Text] [Related]
4. KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast cancer.
Yu B; Luo F; Sun B; Liu W; Shi Q; Cheng SY; Chen C; Chen G; Li Y; Feng H
Adv Sci (Weinh); 2021 Oct; 8(20):e2100014. PubMed ID: 34392614
[TBL] [Abstract] [Full Text] [Related]
5. NanoString technology distinguishes anti-TIF-1γ
Preusse C; Eede P; Heinzeling L; Freitag K; Koll R; Froehlich W; Schneider U; Allenbach Y; Benveniste O; Schänzer A; Goebel HH; Stenzel W; Radke J
Brain Pathol; 2021 May; 31(3):e12957. PubMed ID: 34043263
[TBL] [Abstract] [Full Text] [Related]
6. trim24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.
Zhang LH; Yin YH; Chen HZ; Feng SY; Liu JL; Chen L; Fu WL; Sun GC; Yu XG; Xu DG
Neuro Oncol; 2020 Dec; 22(12):1797-1808. PubMed ID: 32492707
[TBL] [Abstract] [Full Text] [Related]
7. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the trim24/Wnt/β-catenin axis.
Huang L; Li X; Ye H; Liu Y; Liang X; Yang C; Hua L; Yan Z; Zhang X
J Exp Clin Cancer Res; 2020 Apr; 39(1):63. PubMed ID: 32293515
[TBL] [Abstract] [Full Text] [Related]
8. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
[No Abstract] [Full Text] [Related]
9.
Peluffo G; Subedee A; Harper NW; Kingston N; Jovanović B; Flores F; Stevens LE; Beca F; Trinh A; Chilamakuri CSR; Papachristou EK; Murphy K; Su Y; Marusyk A; D'Santos CS; Rueda OM; Beck AH; Caldas C; Carroll JS; Polyak K
Cancer Res; 2019 Aug; 79(16):4173-4183. PubMed ID: 31239270
[TBL] [Abstract] [Full Text] [Related]
10. [Dermatomyositis and Autoantibodies].
Fujimoto M
Brain Nerve; 2018 Apr; 70(4):427-438. PubMed ID: 29632290
[TBL] [Abstract] [Full Text] [Related]
11. trim24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.
Lv D; Li Y; Zhang W; Alvarez AA; Song L; Tang J; Gao WQ; Hu B; Cheng SY; Feng H
Nat Commun; 2017 Nov; 8(1):1454. PubMed ID: 29129908
[TBL] [Abstract] [Full Text] [Related]
12. Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through trim24 Binding.
Lv D; Jia F; Hou Y; Sang Y; Alvarez AA; Zhang W; Gao WQ; Hu B; Cheng SY; Ge J; Li Y; Feng H
Cancer Res; 2017 Nov; 77(22):6190-6201. PubMed ID: 29021135
[TBL] [Abstract] [Full Text] [Related]
13. [Myositis-specific autoantibodies].
Fujimoto M
Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
[TBL] [Abstract] [Full Text] [Related]
14. HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressor.
Lalonde JP; Lim R; Ingley E; Tilbrook PA; Thompson MJ; McCulloch R; Beaumont JG; Wicking C; Eyre HJ; Sutherland GR; Howe K; Solomon E; Williams JH; Klinken SP
J Biol Chem; 2004 Feb; 279(9):8181-9. PubMed ID: 14662771
[TBL] [Abstract] [Full Text] [Related]
15. Synergistic action of genistein and cisplatin on growth inhibition and cytotoxicity of human medulloblastoma cells.
Khoshyomn S; Manske GC; Lew SM; Wald SL; Penar PL
Pediatr Neurosurg; 2000 Sep; 33(3):123-31. PubMed ID: 11096359
[TBL] [Abstract] [Full Text] [Related]
16. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
Albain KS; Rusch VW; Crowley JJ; Rice TW; Turrisi AT; Weick JK; Lonchyna VA; Presant CA; McKenna RJ; Gandara DR
J Clin Oncol; 1995 Aug; 13(8):1880-92. PubMed ID: 7636530
[TBL] [Abstract] [Full Text] [Related]
